Skip to main content
Erschienen in: Cancer Causes & Control 9/2017

02.08.2017 | Letter to the editor

How will the ‘cancer moonshot’ impact health disparities?

verfasst von: Amelie G. Ramirez, Ian M. Thompson

Erschienen in: Cancer Causes & Control | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

In 1971, President Nixon signed into law the National Cancer Act (NCA), colloquially known as the “War on Cancer”, which pushed cancer onto the national agenda and is credited for many subsequent increases in the knowledge of the molecular, cellular, and genetic causes and effects of cancer. But even though cancer mortality has declined overall in intervening years after the NCA, cancer health disparities persist in the form of higher cancer incidence and mortality rates among certain cancer types and certain populations. Breast and cervical cancers disproportionately affect African American, Hispanic, and American Indian Women. Colorectal cancer is the second leading cause of death for Latinos (with men and women combined). Forty-five years after the NCA, how will the next enormous cancer initiatives—President Barack Obama’s Cancer Moonshot and the All of Us Research Program (formerly the Precision Medicine Initiative Cohort Program)—impact cancer health disparities? The emergence of precision medicine and the sharing of information across sectors are at the heart of these large national initiatives and hold vast potential to address complex health disparities that remain in incidence reporting, incidence, treatment, prognoses, and mortality among certain cancer types and racial/ethnic minorities, including African Americans and Hispanics/Latinos, compared to Whites. But clinical research efforts and data collection have historically lacked diverse representation for various reasons, posing a large risk to these national initiatives in their ability to develop diverse cohorts that adequately represent racial/ethnic minorities. Efforts to reduce disparities and increase diversity in study cohorts have emerged, from patient navigation, to use of mobile technology to collect data, to national consortiums dedicated to including diverse groups, to university training on health disparities. These efforts point to the need for the Cancer Moonshot and precision medicine leaders to develop a multifaceted approach to address disparities in health and healthcare to promote a diverse healthcare workforce, patient-centered care, maintenance of a database of information regarding the state of health disparities, and the institution of measurable goals for improving care across all ethnic groups. If these elements are included, it is possible that the Cancer Moonshot and precision medicine will benefit the entire population of our country.
Literatur
2.
Zurück zum Zitat Institute of Medicine (US) (1999) In: Haynes MA, Smedley BD (eds) Committee on cancer research among minorities and the medically underserved. National Academies Press, Washington, DC Institute of Medicine (US) (1999) In: Haynes MA, Smedley BD (eds) Committee on cancer research among minorities and the medically underserved. National Academies Press, Washington, DC
3.
Zurück zum Zitat Rebbeck TR (2006) Conquering cancer disparities: new opportunities for cancer epidemiology, biomarker and prevention research. Cancer Epidemiol Biomark Prev 15:1569–1571CrossRef Rebbeck TR (2006) Conquering cancer disparities: new opportunities for cancer epidemiology, biomarker and prevention research. Cancer Epidemiol Biomark Prev 15:1569–1571CrossRef
4.
Zurück zum Zitat Kolata G, Harris G (2016) ‘Moonshot’ to cure cancer, led by Biden, relies on outmoded view of disease. The New York Times. http://nyti.ms/1OQi3Tz. Accessed 23 Jan 2016 Kolata G, Harris G (2016) ‘Moonshot’ to cure cancer, led by Biden, relies on outmoded view of disease. The New York Times. http://​nyti.​ms/​1OQi3Tz. Accessed 23 Jan 2016
7.
Zurück zum Zitat Disparities in Cancer Care (2006). J Oncol Pract 2(5): 234–239 Disparities in Cancer Care (2006). J Oncol Pract 2(5): 234–239
10.
Zurück zum Zitat Siegel RL, Miller KD, Goding-Sauer A, Pinheiro PS, Martinez-Tyson D, Jemal A (2015) Cancer statistics for Hispanics/Latinos, 2015. CA Cancer J Clin 65:457–480CrossRefPubMed Siegel RL, Miller KD, Goding-Sauer A, Pinheiro PS, Martinez-Tyson D, Jemal A (2015) Cancer statistics for Hispanics/Latinos, 2015. CA Cancer J Clin 65:457–480CrossRefPubMed
11.
Zurück zum Zitat Davis JL, Ramos R, Rivera-Colon V et al (2014) The Yo me cuido program: addressing breast cancer screening and prevention among hispanic women. J Cancer Educ 30:439–446CrossRef Davis JL, Ramos R, Rivera-Colon V et al (2014) The Yo me cuido program: addressing breast cancer screening and prevention among hispanic women. J Cancer Educ 30:439–446CrossRef
13.
Zurück zum Zitat Anderson GL, Barrington WE (2016) Narrowing of racial disparities in breast cancer incidence: insights from menopausal hormone therapy study findings. J Natl Cancer Inst 108(4):1–3CrossRef Anderson GL, Barrington WE (2016) Narrowing of racial disparities in breast cancer incidence: insights from menopausal hormone therapy study findings. J Natl Cancer Inst 108(4):1–3CrossRef
14.
Zurück zum Zitat Al-Alem U, Rauscher G, Shah E et al (2014) Association of genetic ancestry with breast cancer in ethnically diverse women from Chicago. PLoS ONE 9(11):e112916CrossRefPubMedPubMedCentral Al-Alem U, Rauscher G, Shah E et al (2014) Association of genetic ancestry with breast cancer in ethnically diverse women from Chicago. PLoS ONE 9(11):e112916CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Connor AE, Baumgartner RN, Baumgartner KB et al (2015) Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non-Hispanic white women: the breast cancer health disparities study. Mol Carcinog 54:1541–1553CrossRefPubMed Connor AE, Baumgartner RN, Baumgartner KB et al (2015) Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non-Hispanic white women: the breast cancer health disparities study. Mol Carcinog 54:1541–1553CrossRefPubMed
16.
Zurück zum Zitat Carpenter WR, Tyree S, Wu Y et al (2012) A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trials. Clin Trials 9(4):426–435CrossRefPubMedPubMedCentral Carpenter WR, Tyree S, Wu Y et al (2012) A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trials. Clin Trials 9(4):426–435CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Nishi A, Milner DA, Giovannucci EL et al (2016) Integration of molecular pathology, epidemiology and social science for global precision medicine. Expert Rev Mol Diagn 16(1):11–23CrossRefPubMed Nishi A, Milner DA, Giovannucci EL et al (2016) Integration of molecular pathology, epidemiology and social science for global precision medicine. Expert Rev Mol Diagn 16(1):11–23CrossRefPubMed
18.
Zurück zum Zitat London L, Hurtado-de-Mendoza A, Song M, Nagirimadugu A, Luta G, Sheppard VB (2015) Motivators and barriers to Latinas’ participation in clinical trials: the role of contextual factors. Contemp Clin Trials 40:74–80CrossRefPubMed London L, Hurtado-de-Mendoza A, Song M, Nagirimadugu A, Luta G, Sheppard VB (2015) Motivators and barriers to Latinas’ participation in clinical trials: the role of contextual factors. Contemp Clin Trials 40:74–80CrossRefPubMed
19.
Zurück zum Zitat Kwiatkowski K, Coe K, Bailar JC, Swanson GM (2013) Inclusion of minorities and women in cancer clinical trials, a decade later: have we improved? Cancer 119(16):2956–2963CrossRefPubMed Kwiatkowski K, Coe K, Bailar JC, Swanson GM (2013) Inclusion of minorities and women in cancer clinical trials, a decade later: have we improved? Cancer 119(16):2956–2963CrossRefPubMed
20.
Zurück zum Zitat Dean M, Boland J, Yeager M et al (2015) Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2. GigaScience 4:50CrossRefPubMedPubMedCentral Dean M, Boland J, Yeager M et al (2015) Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2. GigaScience 4:50CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Rangel LBA, Taraba JL, Frei CR, Smith L, Rodriguez G, Kuhn JG (2014) Pharmacogenomic diversity of tamoxifen metabolites and estrogen receptor genes in Hispanics and non-Hispanic whites with breast cancer. Breast Cancer Res Treat 148(3):571–580CrossRefPubMedPubMedCentral Rangel LBA, Taraba JL, Frei CR, Smith L, Rodriguez G, Kuhn JG (2014) Pharmacogenomic diversity of tamoxifen metabolites and estrogen receptor genes in Hispanics and non-Hispanic whites with breast cancer. Breast Cancer Res Treat 148(3):571–580CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Moyer VA (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related breast cancer in women: U.S. preventive services task force recommendation statement. Ann Intern Med 160:271–281PubMed Moyer VA (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related breast cancer in women: U.S. preventive services task force recommendation statement. Ann Intern Med 160:271–281PubMed
24.
Zurück zum Zitat Chalela P, Pagan JA, Su D, Munoz E, Ramirez A (2012) Breast cancer genetic testing awareness, attitudes and intentions of Latinas living along the U.S. Mexico border: a qualitative study. J Community Med Health Educ 2:1–15 Chalela P, Pagan JA, Su D, Munoz E, Ramirez A (2012) Breast cancer genetic testing awareness, attitudes and intentions of Latinas living along the U.S. Mexico border: a qualitative study. J Community Med Health Educ 2:1–15
25.
Zurück zum Zitat Ponce NA, Ko M, Liang SY et al (2015) Early diffusion of gene expression profiling in breast cancer patients associated with areas of high income inequality. Health Aff (Millwood). 34(4):609–615CrossRefPubMed Ponce NA, Ko M, Liang SY et al (2015) Early diffusion of gene expression profiling in breast cancer patients associated with areas of high income inequality. Health Aff (Millwood). 34(4):609–615CrossRefPubMed
26.
Zurück zum Zitat Lee JA, Roehrig CS, Duggan Butto E (2016) Cancer cost trends in the United States: 1998 to 2012. Cancer 122:1078–1084CrossRefPubMed Lee JA, Roehrig CS, Duggan Butto E (2016) Cancer cost trends in the United States: 1998 to 2012. Cancer 122:1078–1084CrossRefPubMed
27.
Zurück zum Zitat Dusetzina SB, Keating NL (2016) Mind the gap: why closing the doughnut hole is insufficient for increasing medicare beneficiary access to oral chemotherapy. J Clin Oncol 34(4):375–382CrossRefPubMed Dusetzina SB, Keating NL (2016) Mind the gap: why closing the doughnut hole is insufficient for increasing medicare beneficiary access to oral chemotherapy. J Clin Oncol 34(4):375–382CrossRefPubMed
29.
Zurück zum Zitat Kircher SM, Meeker CR, Nimeiri H et al (2016) The parity paradigm: can legislation help reduce the cost burden of oral anticancer medications? Value Health 19:88–98CrossRefPubMed Kircher SM, Meeker CR, Nimeiri H et al (2016) The parity paradigm: can legislation help reduce the cost burden of oral anticancer medications? Value Health 19:88–98CrossRefPubMed
31.
Zurück zum Zitat Ko NY, Darnell JS, Calhoun E et al (2014) Can patient navigation improve receipt of recommended breast cancer care? Evidence from the national patient navigation research program. J Clin Oncol 32:2758–2764CrossRefPubMedPubMedCentral Ko NY, Darnell JS, Calhoun E et al (2014) Can patient navigation improve receipt of recommended breast cancer care? Evidence from the national patient navigation research program. J Clin Oncol 32:2758–2764CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Braun KL, Stewart S, Bacquet C et al (2015) The national cancer institute’s community networks program initiative to reduce cancer health disparities: outcomes and lessons learned. Prog Community Health Partnersh 9:21–32CrossRefPubMedPubMedCentral Braun KL, Stewart S, Bacquet C et al (2015) The national cancer institute’s community networks program initiative to reduce cancer health disparities: outcomes and lessons learned. Prog Community Health Partnersh 9:21–32CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Biggers A, Shi Y, Charlson J, Smith EC, Smallwood AJ, Nattinger AB, Laud PW, Neuner JM (2016) Medicare D subsidies and racial disparities in persistence and adherence with hormonal therapy. J Clin Oncol 34(36):4398–4404CrossRefPubMedPubMedCentral Biggers A, Shi Y, Charlson J, Smith EC, Smallwood AJ, Nattinger AB, Laud PW, Neuner JM (2016) Medicare D subsidies and racial disparities in persistence and adherence with hormonal therapy. J Clin Oncol 34(36):4398–4404CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Bethea TN, Kitahara CM, Sonderman J, Patel AV, Harvey C, Knutsen SF, Park Y, Park SY, Fraser GE, Jacobs EJ, Purdue MP, Stolzenberg-Solomon RZ, Gillanders EM, Blot WJ, Palmer JR, Kolonel LN (2014) A pooled analysis of body mass index and pancreatic cancer mortality in African Americans. Cancer Epidemiol Biomark Prev 23(10):2119–2125. doi:10.1158/1055-9965.EPI-14-0422 CrossRef Bethea TN, Kitahara CM, Sonderman J, Patel AV, Harvey C, Knutsen SF, Park Y, Park SY, Fraser GE, Jacobs EJ, Purdue MP, Stolzenberg-Solomon RZ, Gillanders EM, Blot WJ, Palmer JR, Kolonel LN (2014) A pooled analysis of body mass index and pancreatic cancer mortality in African Americans. Cancer Epidemiol Biomark Prev 23(10):2119–2125. doi:10.​1158/​1055-9965.​EPI-14-0422 CrossRef
37.
Zurück zum Zitat Clarke T. Jo Biden Announces Next Steps in ‘Cancer Moonshot,’ Reuters Clarke T. Jo Biden Announces Next Steps in ‘Cancer Moonshot,’ Reuters
47.
Zurück zum Zitat Liedtke JA (1995) Changing the organizational culture of technology education to attract minorities and women. Technol Teach 54:9 Liedtke JA (1995) Changing the organizational culture of technology education to attract minorities and women. Technol Teach 54:9
Metadaten
Titel
How will the ‘cancer moonshot’ impact health disparities?
verfasst von
Amelie G. Ramirez
Ian M. Thompson
Publikationsdatum
02.08.2017
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 9/2017
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-017-0927-6

Weitere Artikel der Ausgabe 9/2017

Cancer Causes & Control 9/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.